Co-founder, graduated in Chemistry at the University of Naples in 1991. He has spent the first 10 years of his career as industrial researcher, working as head of the protein and peptide laboratory at Tecnogen S.p.A. and contributing at the development of several bioactive molecules.
In 2002, he joined the Institute of Biostructures and Bioimaging of the National Research Council (IBB-CNR) in Naples, as senior scientist, leading since then several projects funded by public and private agencies and companies. Its research is focused on the development of new bioactive compounds and monoclonal antibodies against therapeutic targets in cancer and other diseases. Among the others, he has developed peptides modulating the activity of PlGF, Cripto, Gadd45β and mAbs against Nodal, the E2 protein of HCV and Cripto. He has been advisor for biotech companies. He was also the scientific founder of Kesios Therapeutics Ltd (London) in 2012. He is author of 100+ papers on ISI journals and inventor of 10+ patents.
He has been advisor for biotech companies. He was also the scientific founder of Kesios Therapeutics Ltd (London) in 2012. He is author of 100+ papers on ISI journals and inventor of 10+ patents.